• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD Back to Search Results
Catalog Number 1012463-28
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Angina (1710); Cardiac Arrest (1762); Myocardial Infarction (1969); Thrombosis (2100); Ventricular Fibrillation (2130); Ventricular Tachycardia (2132)
Event Date 05/10/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).There was no reported device malfunction and the product was not returned as the scaffold remains in the anatomy.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of myocardial infarction, thrombosis, ventricular fibrillation and ventricular tachycardia, as listed in the bioresorbable vascular scaffold (bvs) system, absorb, instructions for use are known adverse events associated with the use of a coronary scaffold in native coronary arteries.Based on the case information and related record review, a conclusive cause for the reported patient effects and the relationship to the product, if any, cannot be determined and there is no indication of a product quality issue with respect to design, manufacture or labeling of the device.
 
Event Description
It was reported that on (b)(6) 2014, the patient underwent a coronary procedure with implantation of a 3.0 x 28 mm absorb bioresorbable vascular scaffold (bvs) in the mid left anterior descending (lad) artery.On (b)(6) 2017, the patient experienced chest pain and was transported to the hospital via ambulance.During the ride to the hospital, the patient experienced ventricular fibrillation cardiac arrest and was treated with cardiopulmonary resuscitation (cpr) and defibrillation.The patient returned to spontaneous circulation.The patient went into cardiac arrest again while in the emergency room and was treated with cpr and defibrillation.The patient went into pulseless electrical activity (pea) and required additional cpr, as well as adrenaline.The patient returned to spontaneous circulation, but was in ventricular tachycardia.Three synchronized shocks and amiodarone were administered and the patient went into normal sinus rhythm with st elevation myocardial infarction.The patient was transferred to another facility for percutaneous coronary intervention.Coronary angiography noted that the implanted scaffold was occluded with thrombus.A stent was implanted at the target lesion in the lad.The patient condition resolved on (b)(6) 2017 and medications were changed from aspirin and clopidogrel to aspirin and ticagrelor.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
BIORESORBABLE DRUG ELUTING SCAFFOLD
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key7268408
MDR Text Key99987423
Report Number2024168-2018-01074
Device Sequence Number1
Product Code PNY
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P150023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,s
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial
Report Date 02/13/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/13/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/06/2015
Device Catalogue Number1012463-28
Device Lot Number4070761
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/29/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/01/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age63 YR
Patient Weight98
-
-